Short-term use for haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis.
Local fibrinolysis occurs in the following conditions: Prostatectomy and bladder surgery, menorrhagia, epistaxis, conisation of the cervix, traumatic hyphaema, management of dental extraction in patients with coagulopathies, ulcerative colitis, hematuria, gastrointestinal haemorrhage.
General fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery; in obstetrical complication eg, abruptio placenta and postpartum haemorrhage; in leukemia and liver diseases and in connection with thrombolytic therapy with streptokinase.
Hereditary angioneurotic oedema.